Unknown OBSERVATIONAL NCT05405296

Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2) (Truenat COMBO)

Performance Evaluation of the Molbio Diagnostics Truenat™MTB Plus/COVID-19for TB and COVID-19case Detection Using Prospectively Collected NP (Nasopharyngeal) Swabs and Sputum Samples From Participants With Symptoms Suggestive of TB

Sponsor: Foundation for Innovative New Diagnostics, Switzerland

Conditions COVID-19 TB

Interventions Truenat™ MTB Plus/COVID-19

Updated 5 times since 2022 Last updated: Jan 17, 2024 Started: Aug 30, 2022 Primary completion: Apr 30, 2024 Completion: Sep 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19 and TB, this trial is ongoing. The trial is conducted by Foundation for Innovative New Diagnostics, Switzerland and has accumulated 5 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Active Not Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Feb 2024 — Jul 2024 [monthly]

Active Not Recruiting

Status: Not Yet Recruiting → Active Not Recruiting
Jul 2022 — Feb 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Foundation for Innovative New Diagnostics, Switzerland

Data source: Foundation for Innovative New Diagnostics, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kampala, Uganda